Regulation of P-Glycoprotein in the Brain.

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• The blood-brain barrier (BBB) maintains brain homeostasis.
• P-glycoprotein (P-gp) on the BBB limits neurotoxic compound entry.
• Altered P-gp levels are linked to aging, neurodegeneration, and drug efficacy.

Purpose of the Study:

• To review the complex regulation of P-gp at the BBB.
• To explore mechanisms influencing P-gp expression and activity.
• To inform strategies for therapeutic modulation of P-gp.

Main Methods:

• Literature review of transcriptional, post-transcriptional, and post-translational regulation.
• Synthesis of current understanding of P-gp control mechanisms.
• Analysis of P-gp's role in brain homeostasis and drug pharmacokinetics.

Main Results:

• P-gp expression and activity are modulated by intricate regulatory pathways.
• Ageing and neurodegenerative diseases are associated with decreased P-gp function.
• Increased P-gp at the BBB can impede central nervous system drug delivery.

Conclusions:

• Understanding P-gp regulation is crucial for addressing neurological disorders and improving drug therapies.
• Targeting P-gp regulatory mechanisms offers potential therapeutic benefits.
• Further research into P-gp modulation can enhance brain drug delivery and treatment outcomes.